QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Vol. 17, Issue 2, 585-597, February 2006

This Article Full Text Full Text (PDF) Supplemental Material All Versions of this Article: E05-08-0775v1 17/2/585    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Liu, F. Articles by Kao, G. D. Search for Related Content PubMed PubMed Citation Articles by Liu, F. Articles by Kao, G. D.

Regulation of Histone Deacetylase 4 Expression by the SP Family of Transcription Factors

Department of Radiation Oncology, Philadelphia Veterans Affairs Medical Center, and the University of Pennsylvania School of Medicine, Philadelphia, PA 19104

Submitted August 18, 2005; Revised October 25, 2005; Accepted November 2, 2005
Monitoring Editor: William Tansey

Histone deacetylases mediate critical cellular functions but relatively little is known about mechanisms controlling their expression, including expression of HDAC4, a class II HDAC implicated in the modulation of cellular differentiation and viability. Endogenous HDAC4 mRNA, protein levels and promoter activity were all readily repressed by mithramycin, suggesting regulation by GC-rich DNA sequences. We validated consensus binding sites for Sp1/Sp3 transcription factors in the HDAC4 promoter through truncation studies and targeted mutagenesis. Specific and functional binding by Sp1/Sp3 at these sites was confirmed with chromatin immunoprecipitation (ChIP) and electromobility shift assays (EMSA). Cotransfection of either Sp1 or Sp3 with a reporter driven by the HDAC4 promoter led to high activities in SL2 insect cells (which lack endogenous Sp1/Sp3). In human cells, restored expression of Sp1 and Sp3 up-regulated HDAC4 protein levels, whereas levels were decreased by RNA-interference-mediated knockdown of either protein. Finally, variable levels of Sp1 were in concordance with that of HDAC4 in a number of human tissues and cancer cell lines. These studies together characterize for the first time the activity of the HDAC4 promoter, through which Sp1 and Sp3 modulates expression of HDAC4 and which may contribute to tissue or cell-line-specific expression of HDAC4.

The online version of this article contains supplemental material at MBC Online (http://www.molbiolcell.org).

Address correspondence to: Gary D. Kao (Kao{at}xrt.upenn.edu).

This article has been cited by other articles:

				A. J. Wilson, D.-S. Byun, S. Nasser, L. B. Murray, K. Ayyanar, D. Arango, M. Figueroa, A. Melnick, G. D. Kao, L. H. Augenlicht, et al. HDAC4 Promotes Growth of Colon Cancer Cells via Repression of p21 Mol. Biol. Cell, October 1, 2008; 19(10): 4062 - 4075. [Abstract] [Full Text] [PDF]

				J. Hata, K. Matsuda, T. Ninomiya, K. Yonemoto, T. Matsushita, Y. Ohnishi, S. Saito, T. Kitazono, S. Ibayashi, M. Iida, et al. Functional SNP in an Sp1-binding site of AGTRL1 gene is associated with susceptibility to brain infarction Hum. Mol. Genet., March 15, 2007; 16(6): 630 - 639. [Abstract] [Full Text] [PDF]